Dividends4Life: Abbvie Inc. (ABBV) Trading At A Deep Discount, But With Risks

Linked here is a detailed quantitative analysis of Abbvie Inc. (ABBV). Below are some highlights from the above linked analysis:

Company Description: Abbvie Inc. is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories at the start of 2013. AbbVie's key drug is Humira for rheumatoid arthritis.


Click here to have future posts delivered to you for free!



Post a Comment


Latest From Dividend Growth Stocks

Popular Posts Last 30 Days